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Introduction 
Cholecystectomy is a widely practised and usually very safe
procedure, although its potential complications are well
recognised and widely reported [1]. Neoplasms developing
as a result of cholecystectomy, or any other routine surgical
procedure, are rare in the literature. We report a case of
hepatocellular carcinoma (HCC) directly associated with a
preceding cholecystectomy.
Case report
In December 1992 a 63-year-old non-smoking woman was
referred to the Scottish Liver Transplant Unit. She had
undergone cholecystectomy for cholelithiasis 19 years
previously. The operation had been complicated by tran-
section of the common bile duct and was followed three
weeks later by choledochoduodenostom y. She subsequently
had intermittent episodes of cholangitis and was exten-
sively reinvestigated five years later. Ultrasonography
revealed parenchymal liver disease and splenomegaly. Liver
biopsy showed secondary biliary cirrhosis with no excess of
iron, copper or alpha-1 antitrypsin; cholescintigram was
normal with no evidence of biliary obstruction. An upper
gastrointestinal endoscopy revealed early varices.
Fifteen years after the original operation, she presented
with haemorrhage from her varices and required multiple
blood transfusions. She was managed by injection scle-
rotherapy but subsequently required oesophageal dilatation
for stricturing caused by the sclerotherapy.
When she was referred to our unit four years later, she
had a two-year history of intermittent episodes of encepha-
lopathy. Her liver function tests were deranged: serum
bilirubin 34 l mol/l (normal 2–17), alkaline phosphatase
220 U/l (40–125), gamma-glutamyl transferase 293 U/l
(5–35), albumin 30g/l (36–47), prothrombin time 16 sec-
onds (control 12 seconds). Hepatitis B and C virus serology
and serological measurements of anti-nuclear factor, anti-
mitochondrial antibody and anti-smooth muscle antibody
were all negative. Serum alpha-fetoprotein was 4 iu/l (nor-
mal 2–6). A barium meal demonstrated stenosis of both
the duodenum and bile duct at the site of the anastomosis
and reflux of barium into the biliary system with evidence
of a dilated intrahepatic biliary tree. Ultrasound scan and
hepatic angiogram revealed no evidence of any focal
parenchymal hepatic lesions. The angiogram showed portal
hypertension and reversal ofportal venous flow. In view of her
impaired hepatic function, orthotopic liver transplantation
was undertaken in March 1993.
Within the resected liver was a 1.5 cm nodule of
moderately differentiated, multinodular, unencapsulated
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hepatocellular carcinoma. The tumour cells did not stain
for hepatitis B surface antigen but were positive for alpha-1
antitrypsin. There was no evidence of vascular, lymphatic
or perineural invasion. The remainder of the liver showed
well established secondary biliary micronodular cirrhosis
with a number of macronodules. 
Initial postoperative recovery was marked by severe
acute graft rejection, which responded to corticosteroids,
and a bile leak, which required refashioning of the biliary
anastomosis. She was discharged 47 days after the trans-
plantation, but developed late stenosis of the biliary-enteric
anastomosis which required surgical revision four months
later. She then developed chronic graft rejection necessi-
tating a second transplantation six months after the first.
Postoperative hepatic artery thrombosis led to an emer-
gency retransplantation procedure one week later, which
failed because of acute rejection. The patient died seven
months after the initial liver transplantation. 
Discussion
Bile duct injury is a major potential complication of chole-
cystectomy, with a reported incidence of 0.07%–0.9% [1,2].
Whether this figure is higher in the era of laparoscopic sur-
gery remains controversial. Bile duct injuries may be
detected and corrected intraoperatively, in the early post-
operative period, or they may present many years after the
operation [3]. Late bile duct stricturing may lead to second-
ary biliary cirrhosis in 6–30% of cases [3,4]. Although
cirrhosis as a result of a previous bile duct injury requiring
liver transplantation has been reported [5], development of
a hepatocellular carcinoma (HCC) in association with
cirrhosis due to a bile duct injury has not. 
It is well recognised that hepatic cirrhosis due to alcohol
abuse, iron overload (haemochromatosis) or copper over-
load (Wilson’s disease) is a risk factor for the development
of HCC, even though in these diseases the ethanol, iron,
and copper that cause the cirrhosis are not currently
thought to be directly carcinogenic. Approximately 70%
of primary HCC arises in cirrhotic livers, and it is cur-
rently hypothesised that the regeneration of cells associ-
ated with cirrhosis may be a tumourgenic process. DNA
synthesis is accelerated in regenerating nodules, and this
may result in increased rearrangement of oncogenic
sequences within the chromosomes. Macronodular cirrhosis
is thought to be more likely to cause HCC than micron-
odular cirrhosis due to the higher level of regenerative
activity [6]. Hepatocyte dysplasia has been described in
association with cirrhosis of various aetiologies [7], but it
remains uncertain whether these dysplastic hepatocytes
are indeed premalignant [8].
In the present case, it is important to note that all other
recognised risk factors for cirrhosis or HCC have been
excluded. The patient had no history of alcohol abuse, and
other possible causes of cirrhosis including haemochro-
matosis, alpha-1 anti-trypsin deficiency, Wilson’s disease,
autoimmune liver disease and viral hepatitis were excluded.
Aside from cirrhosis, hepatitis B virus infection and afla-
toxin exposure are the major independent risk factors for
development of HCC. Hepatitis B has been excluded and
the patient was unlikely to have had appreciable exposure
to occupational or dietary aflatoxin. 
We therefore believe that there is a causative relation-
ship between the cholecystectomy and the occurrence of a
HCC in this patient. The sequence of events was an iatro-
genic bile duct injury during cholecystectomy, which was
repaired by a choledochoduodenostomy. Subsequent steno-
sis of the biliary-enteric anastomosis resulted in episodes of
cholangitis and secondary biliary cirrhosis. HCC developed
on this cirrhotic background. 
The overall risk of developing HCC as a result of chole-
cystectomy can be estimated as follows. The frequency of
bile duct injury due to cholecystectomy is in the range
0.07%–0.9% [1,2,9,10]. Appropriate surgical intervention
usually leads to successful repair of bile duct injuries, but
2–15% of patients will have recurrent complications such
as anastomotic stricturing and cholangitis [11,12], and of
these 6–30% will develop cirrhosis [3,4]. The frequency of
progression from cirrhosis to HCC in hepatitis B and C
virus negative patients has been reported to be 1.0–22.6%
[13,14,15]. Taking the mid-points of these ranges of figures
would give an overall risk of 1:1,140,000 (range 1:11,000
to 1:120,000,000) for developing HCC as a result of
cholecystectomy. As with most neoplastic diseases,
tumourgenesis here is likely to be a multifactorial process
and other as yet undefined aetiological factors might also
be involved.
This case highlights the rare possibility of developing a
malignancy as a result of a very frequent routine surgical
procedure. It should be emphasised that the recommended
repair following bile duct injury is Roux-en-Y hepatico-
jejunostomy with careful follow-up to ensure there is no
evidence of late anastomotic stenosis or secondary biliary
cirrhosis.
RAE Clayton et al.
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